Ugochi Ebinama, MD¹, Rishab Prakash, BS^2*, Paolo Strati, MD², Sairah Ahmed, MD³, Sherry Adkins, ANP^4*, Samer A. Srour, MD⁵, Michael L. Wang, MD⁶, Preetesh Jain, MD, MBBS, PhD, DM⁷, Elizabeth J. Shpall, MD⁵, Anath Lionel, MD^8*, Meng Lui, Ph.D^9*, Sattva S. Neelapu, MD², Krina K. Patel, MD, MSc⁶ and Swami P. Iyer, MD⁷

¹Department of Internal Medicine, The University of Texas Health Science Center McGovern Medical School, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Internal Medicine, The University of Texas at Houston, Houston, TX
⁴MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶University of Texas MD Anderson Cancer Center, Houston, TX
⁷Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma/ Myeloma, Division of Cancer Medicine Houston,, The University of Texas MD Anderson Cancer Center, Houston
⁹Penn State University, Pennsylvania

Christian Brieghel, MD, PhD^1*, Emelie Curovic Rotbain, MD, PhD^1*, Michael Asger Andersen, MD, PhD^2*, Peter de Nully Brown, MD, PhD¹ and Carsten Utoft Niemann, MD, PhD^1*

¹Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
²Department of Clinical Pharmacology, Copenhagen University Hospital – Bispebjerg and Frederiksberg Hospital, Copenhagen Ø, Denmark

Juan Pablo Alderuccio, MD¹, Michele D. Stanchina, DO, MS², Jean L. Koff, MD, MSc³, Isildinha M. Reis, PhD^4*, Eduardo Edelman Saul, MD^5*, Melissa C. Larson, MS^6*, Dai Chihara, MD, PhD⁷, Wei Zhao, MD, MS^8*, Thomas M. Habermann, MD⁹, Peter Martin, MD¹⁰, Loretta J. Nastoupil, MD¹¹, Jennifer R. Chapman-Fredricks, MD^12*, Andrew L. Feldman, MD¹³, Brian K. Link, MD^14*, Brad S. Kahl, MD¹⁵, Jonathon B. Cohen, MD, MS¹⁶, Mark K Polar, MD^17*, Rafael Henneman Sassi, MD^18*, Craig H. Moskowitz, MD¹⁹, Jonathan W. Friedberg, MD, MMSc²⁰, James R. Cerhan, MD, PhD²¹, Russ Kuker, MD^22*, Christopher R. Flowers, MD, MS⁷ and Izidore S. Lossos, MD²³

¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami
³Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁴Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, FL
⁵Sylvester Comprehensive Cancer Center, Miami
⁶Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Sylvester Comprehensive Cancer Center, Department of Public Health Sciences, Miami
⁹Division of Hematology, Mayo Clinic, Rochester, MN
¹⁰Weill Cornell Medicine, New York
¹¹MD Anderson Cancer Center, Houston, TX
¹²University of Miami Miller School of Medicine, Miami, FL
¹³Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
¹⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
¹⁵Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
¹⁶Winship Cancer Institute, Emory University, Atlanta, GA
¹⁷Department of Radiology, Division of Nuclear Medicine, University of Miami Miller School of Medicine, Miami
¹⁸Sylvester Comprehensive Cancer Center, Department of Medicine, Miami
¹⁹Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
²⁰Wilmot Cancer Center, University of Rochester, Rochester, NY
²¹Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
²²Department of Radiology, Division of Nuclear Medicine, University of Miami, Miller School of Medicine, Miami, FL
²³Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL

Nosakhare Paul Ilerhunmwuwa, MBBS, MSc¹, Henry Becerra, MD^1*, Mustafa Wasifuddin, MD^2*, Ogechi Ogonnaya Agogbuo, MD^3*, Aditya Keerthi Rayapureddy, MD^4* and Jen-Chin Wang, MD⁵

¹Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
²Brookdale University Hospital and Medical Center, Brooklyn, NY
³Texas A&M School of Medicine with Christus Health, Longview, TX
⁴Department of Medicine, Interfaith Medical Center, Brooklyn, NY
⁵Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY

Jenny M.H. Chen^1*, Ina Zhang, MPH^2*, James J. Wu, MPH, MSc^3*, Sally W. Wade, MPH^4*, Ana Nunes, PharmD^3*, Weimin Peng^3*, Julia T. Snider, PhD^3*, Dylan Maciel, MSc^1*, Keith Chan, MSc^1*, Sam Keeping, MSc^5* and Bijal D. Shah, MD⁶

¹PRECISIONheor, Vancouver, BC, Canada
²PRECISIONheor, Oakland, CA
³Kite, a Gilead Company, Santa Monica, CA
⁴Wade Outcomes Research & Consulting, Salt Lake City, UT
⁵PRECISIONheor, Vancouver, BC, CAN
⁶Moffitt Cancer Center and Research Institute, Tampa, FL

Bijal D. Shah, MD¹, Mei Xue, MBA^2*, Erlene Kuizon Seymour, MD², Wesley Furnback, BA^3*, Po-Ya Chuang, MHA^3* and Keri Yang, PhD, MBA, MPH, MS, CPM, BSPharm^2*

¹Moffitt Cancer Center and Research Institute, Tampa, FL
²BeiGene USA, Inc, San Mateo, CA
³Real Chemistry, Inc, New York City, NY

Gabriel Brisou^1*, Guillaume Cartron, MD, Ph-D^2*, Emmanuel Bachy, MD, PhD^3*, Catherine Thieblemont, MD^4*, Cristina Castilla-Llorente, MD^5*, Fabien Le Bras, MD^6*, François-Xavier Gros^7*, Michael Loschi, MD, PhD^8*, Roch Houot, MD, PhD^9*, Remy Dulery, MD, PhD^10*, Fabrice Jardin, MD PhD^11*, Magalie Joris, MD^12*, Choquet Sylvain^13*, Franck Morschhauser, MD PhD¹⁴, Stephanie Guidez^15*, Olivier Hermine¹⁶, Laurianne Drieu La Rochelle^17*, Sylvain Carras^18*, Blandine Guffroy, MD^19*, Pierre Bories, MD, PhD^20*, Rene-Olivier Casasnovas, MD^21*, Julie Abraham^22*, Steven Le Gouill, MD, PhD²³, Pascale Cony-Makhoul, MD^24*, Elodie Gat^25* and Benoit Tessoulin^26*

¹Institut Paoli-Calmettes, Department of Hematology, Marseille Cedex 09, France
²Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
³Lyon-Sud Hospital Center, Pierre-Bénite, France
⁴Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France
⁵Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
⁶Clinical Hematology, Henri-Mondor Hospital, Assistance Publique - Hôpitaux de Paris, Paris, FRA
⁷Hôpital Du Haut-Lévèque, CHU de Bordeaux, Pessac, FRA
⁸Centre Hospitalier Universitaire de Nice, Nice, France
⁹Clinical Hematology, INSERM U1236, EFS, Hopital Pontchaillou, Rennes University Hospital, Rennes, France
¹⁰Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France
¹¹Centre Henri-Becquerel and University of Rouen, Rouen, France
¹²Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, FRA
¹³Hopital de la Pitié Salpetrière, APHP, Paris, FRA
¹⁴Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, AL, France
¹⁵Hematolgy department, University Hospital of Poitiers, Poitiers, France
¹⁶Department of Hematology, Necker Hospital, APHP, Paris, France
¹⁷CHU TOURS, Tours, FRA
¹⁸Hematology, CHU GRENOBLE - HÔPITAL ALBERT MICHALLON, Grenoble, France
¹⁹Hematology department, INSTITUT DE CANCÉROLOGIE STRASBOURG EUROPE (ICANS), Strasbourg, FRA
²⁰Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
²¹CHU DE DIJON - HÔPITAL F. MITTERRAND, Dijon, FRA
²²CHU DE LIMOGES - HÔPITAL UNIVERSITAIRE DUPUYTREN, Limoges, FRA
²³Hematology Department, Institut Curie, Paris, France
²⁴Lymphoma Academic Research Organisation (LYSARC), Pierre-Bénite, France
²⁵Lymphoma Academic Research Organisation (LYSARC), Pierre Bénite, France
²⁶Hematology Department, CHU Nantes, Nantes, France

Paolo Strati, MD¹, Amanda Brandt^2*, Jared Henderson^3*, Jason Westin, MD⁴, Loretta J. Nastoupil, MD⁵, Ajlan Al Zaki, MD, PhD⁶, Andrew P Jallouk, MD, PhD⁷, Sherry Adkins, ANP^5*, Elizabeth J. Shpall, MD⁸, Partow Kebriaei, MD⁸, Jeremy Ramdial, MD⁸, Neeraj Y. Saini, MD⁸, Sairah Ahmed, MD⁹, Christopher R. Flowers, MD, MS¹, Sattva S. Neelapu, MD¹ and Michelle Hildebrandt, PhD¹⁰

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston
³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
⁵MD Anderson Cancer Center, Houston, TX
⁶Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
⁸Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰The University of Texas MD Anderson Cancer Center, Houston, TX

Jun Yang Jiang, MD^1*, Chijioke Nze, MD, MPH², Danielle Guffey^3*, Rockbum Kim¹, Abiodun O. Ouyomi^4*, Omar Rosales^4*, Raka Bandyo^5*, Akiva Diamond, MD¹, Gustavo A. Rivero, MD^1*, Courtney Nicole Miller-Chism, MD⁶, Mark M. Udden, MD¹, Martha P. Mims, MD, PhD¹, Christopher R. Flowers, MD, MS⁷, Ang Li, MD, MS¹ and Purnima Sravanti Teegavarapu, MD¹

¹Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
²Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
³Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX
⁴Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX
⁵Harris Health System, Houston, TX
⁶Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Missouri City, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

John L Vaughn, MD, MS¹ and Narendranath Epperla, MD, MS²

¹Smilow Hospitalist Service, Yale New Haven Hospital, New Haven, CT
²The Ohio State University, Columbus, OH

Areej El-Jawahri, MD¹, Jennifer Reese, PhD^2*, Lara Traeger^3*, Don Dizon, MD^4*, Sharon Bober^5*, Julie Vanderklish, ANP^3*, Richard Newcomb^3*, Zachariah Defilipp, MD⁶, Yi-Bin Chen, MD, MS³ and Jennifer Temel^3*

¹Massachusetts General Hospital, Allston, MA
²Fox Chase Cancer Center, Philadelphia, PA
³Massachusetts General Hospital, Boston, MA
⁴Lifespan Cancer Institute, Providence, RI
⁵Dana Farber Cancer Institute, Boston, MA
⁶Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA

Asher Alban Chanan-Khan, MD¹, Swetha Challagulla, MS^2*, Alpana Kaushiva^3*, Vincent Miller^3*, Yuexi Wang^3*, Helen Smith, PhD, MPH^3* and Keri Yang, PhD, MBA, MPH, MS, CPM, BSPharm^2*

¹Mayo Clinic Florida, Jacksonville, FL
²BeiGene USA, Inc, San Mateo, CA
³ConcertAI, Cambridge, MA

Asher Alban Chanan-Khan, MD¹, Swetha Challagulla, MS^2*, Elizabeth Donckels, MSPH^3*, Po-Ya Chuang, MHA^4* and Keri Yang, PhD, MBA, MPH, MS, CPM, BSPharm^2*

¹Mayo Clinic Florida, Jacksonville, FL
²BeiGene USA, Inc, San Mateo, CA
³Real Chemistry, Inc, New York, NY
⁴Real Chemistry, Inc, New York City, NY

Sharlene Dong, MD¹, Ankit J. Kansagra, MD², Gurbakhash Kaur, MD, MA³, Anna Barcellos, MPH^4*, Andrew J. Belli, MPH^4*, Laura L. Fernandes, PhD^4*, Eric Hansen, MS^4*, Jacob Ambrose, MS^4*, Claire Bai, MS^4*, Christina M. Zettler^4* and Ching-Kun Wang, MD^4*

¹Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
²Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
³Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁴COTA, Inc., New York, NY

Alberto Lopez Garcia, MD¹, Ana Isabel Hormigo, MD^2*, Ignacio Mahillo, PhD^3*, Elham Askari, MD^4*, Daniel Morillo, MD^5*, Maria Angeles Perez Saez, MD^4*, Elena Prieto, MD, PhD^5*, Miriam Riesco^6*, Celia Urrutia^6*, Francisco Javier Martinez Peromingo, MD^7*, Juan Ignacio Gonzalez Montalvo, PhD^8* and Raul Cordoba, MD, PhD⁹

¹Fundacion Jimenez Diaz University Hospital, Madrid, Spain
²Geriatric Department, Fundacion Jimenez Diaz, Madrid, Spain
³Biostatics Department, Fundacion Jimenez Diaz, Madrid, Spain
⁴Hematology Department, Fundacion Jimenez Diaz, Madrid, Spain
⁵Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
⁶Oncohealth Institute, Fundacion Jimenez Diaz, Madrid, Spain
⁷General Director of Sociosanitary Coordination. Community of Madrid., Madrid, Spain
⁸Geriatrics Department, La Paz University Hosital, Madrid, Spain
⁹Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain

Narendranath Epperla, MD, MS¹, Kaitlin Annunzio, DO², Geoffrey P. Shouse, PhD, DO³, Natalie S. Grover, MD⁴, Pallawi Torka, MD⁵, Marcus P Watkins, PhD^6*, Andrea Carolina Anampa-Guzmán, MD^7*, Timothy S. Oh, MD^8*, Heather Reves, MS, BS^9*, Montreh Tavakkoli, MD¹⁰, Emily Hansinger^11*, Beth Christian, MD², Colin Thomas, MD¹¹, Stefan K. Barta, MD¹², Praveen Ramakrishnan Geethakumari, MD, MS¹³, Reem Karmali, MD, MSc¹⁴, Nancy L. Bartlett, MD⁶ and Adam J Olszewski, MD¹⁵

¹The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
²The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
³City of Hope Comprehensive Cancer Center, Duarte, CA
⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁷Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁹Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
¹⁰Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
¹¹Thomas Jefferson University Hospital, Philadelphia, PA
¹²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
¹³Section of Hematological Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
¹⁴Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁵Brown University, Providence, RI

Angela N Johnson, PhD^1,2, Arthur Fulgoni, M.Eng^3*, Limin Wang, PhD^4*, Sandra Racordon-Pape^5* and Magnus Almgren^6*

¹School of Professional Studies, Regulatory Affairs Program, Northeastern Univerity, Woburn, MA
²Global Regulatory Compliance, Cytiva, Marlborough, MA
³Cytiva, Marlborough, MA
⁴Regulatory Compliance Leader, Cytiva, Marlborough, MA
⁵Cytiva Global Regulatory Strategy, 1262 Eysins, 41763055318, Switzerland
⁶Cytiva Global Regulatory Compliance, Uppsala, Sweden

Chaitra S Ujjani, MD¹, Ted Gooley, PhD^2*, Tanya Siddiqi, MD³, Deborah M. Stephens, DO⁴, Catherine Broome, MD⁵, Stephen E Spurgeon, MD⁶, Catherine Lai, MD^7,8, Allison Winter, MD⁹, Georgios Pongas, MD¹⁰, Alex Greninger^11*, Joshua A. Hill, MD^1*, Susan M. O'Brien¹², Matthew S. Davids, MD, MMSc¹³, Kerry A Rogers, MD¹⁴, Alexey Danilov, MD¹⁵, Genesis Quezada^1*, Haiying Zhu^11*, Amy Sperling^1*, Tyler Sorensen^1*, Kelsey Launchbury^1*, William G. Wierda, MD, PhD¹⁶, Mazyar Shadman, MD, MPH^17* and Philip A. Thompson, MBBS^18*

¹Fred Hutchinson Cancer Center, Seattle, WA
²Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA
³City of Hope, Irvine, CA
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Georgetown University, Washington, DC
⁶Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁷Abramson Cancer Center, Georgetown University Hospital, Washington, DC
⁸Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹⁰University of Miami, Miami, FL
¹¹University of Washington, Seattle, WA
¹²UCI Cancer Center, Laguna Hills, CA
¹³Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
¹⁴Division of Hematology, The Ohio State University, Columbus, OH
¹⁵Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
¹⁶Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁸University of Melbourne, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Australia

Nayan Chaudhary, MS^1*, Sumi Roy, PhD^1*, Chu-Fang Lin, PhD^1*, Maneesh Tandon, MBChB^2*, Antonia Kwan, MBBS, PhD^1*, Peter Kuebler, PharmD^1* and Ashwini Shewade, MS^1*

¹Genentech, Inc., South San Francisco, CA
²F. Hoffmann-La Roche Ltd, Basel, Switzerland

Ryan W Jacobs, MD¹, Anna Teschemaker, PhD^2*, Shweta Hakre, PhD^2*, Hongping Tian, PhD^3*, Nick Pyrih, BS^3*, Svea K. Wahlstrom, VMD, MS^4* and Lianzhou Cui, MS^3*

¹Atrium Health Levine Cancer Institute, Charlotte, NC
²AstraZeneca, Gaithersburg, MD
³Cobbs Creek Health Care, Newtown Square, PA
⁴AstraZeneca, Wilmington, DE

Nitin Jain, MD¹, Toby A. Eyre^2*, Katherine Winfree, PhD, MS, MPH^3*, Naleen Raj Bhandari, PhD^3*, Manoj Khanal, PhD^3*, Tomoko Sugihara, MSc^4*, Paolo Abada, MD⁵ and Krish Patel, MD⁶

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
³Eli Lilly and Company, Indianapolis, IN
⁴FSP Biometrics, Syneos Health, Morrisville, NC
⁵Loxo@Lilly, Indianapolis, IN
⁶Swedish Cancer Institute, Seattle, WA

Tyler B. Sandahl, PharmD^1*, Scott A. Soefje^1*, Ediz S. Calay^2*, Yi Lin, MD, PhD³, Rafael Fonseca, MD⁴, Sikander Ailawadhi⁵, Ricardo Parrondo, MD⁵, Dee Lin^6*, Bingcao Wu^6*, Eli Silvert^2*, Nina Kim^6*, Corinne Carpenter^2*, Tyler E. Wagner^2*, Jessica Fowler, PhD^7*, Laura Hester^8*, Alexander Marshall^9*, Patrick Stoy¹⁰, Dina Gifkins^11* and Shaji Kunnathu Kumar, MD¹²

¹Mayo Clinic, Rochester, MN
²nference Inc., Cambridge, MA
³Mayo Clinic Cancer Center, Rochester, MN
⁴Mayo Clinic, Phoenix, AZ
⁵Mayo Clinic, Jacksonville, FL
⁶Janssen Scientific Affairs, LLC, Horsham, PA
⁷Johnson & Johnson, Horsham, PA
⁸Janssen R&D, LLC, Horsham, PA
⁹Janssen Global Services, LLC, Raritan, NJ
¹⁰Janssen US Medical Affairs, Horsham, PA
¹¹Janssen R&D, LLC, Titusville, NJ
¹²Division of Hematology, Mayo Clinic, Rochester, MN

Bijal D. Shah, MD¹, Mei Xue, MBA^2*, Wesley Furnback, BA^3*, Kaitlyn Esselman^3*, Po-Ya Chuang, MHA^3* and Keri Yang, PhD, MBA, MPH, MS, CPM, BSPharm^2*

¹Moffitt Cancer Center and Research Institute, Tampa, FL
²BeiGene USA, Inc, San Mateo, CA
³Real Chemistry, Inc, New York City, NY

Heidi Latiolais, MD, MSc^1,2, Supreet Kaur, MD³, Michael Mader, MS^1*, Kathleen Franklin, RN^1*, Madison Williams, MD^4*, Ryan Williams, MD^4*, Jean-Pierre Blaize, MD^5*, Amna Naqvi, BS^6*, Snegha Ananth, MBBS⁷, Michael Meansup Song, MD^8*, Brian Warnecke, DO^9*, Abhishek Pandya, DO^1,6*, Lakene Raissa Djoufack Djoumessi, MD^10*, Lindsey Lu, PharmD^1*, Phillip Nazarewicz, BS^1*, Manuel Espinoza-Gutarra, MD^11*, Kana Tai Lucero, MD^1,2*, Jennifer Whitehead, MS^1*, Alaq Al-Abayechi, MD^1*, Lauren Boyle, DO^1,6*, Sophia Lee, MD^1,6, Gabriel Roman Souza, MD¹, Esteban Toro Velez, MD⁶, Ian Mines, DO^1,2 and Zohra Nooruddin, MD¹

¹South Texas Veterans Health Care System, San Antonio, TX
²University of Texas Health Science Center at San Antonio, San Antonio, TX
³University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
⁴University of Texas MD Anderson Cancer Center, Houston, TX
⁵Augusta Oncology, Augusta, GA
⁶University of Texas Health-San Antonio, San Antonio, TX
⁷Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
⁸Baylor College of Medicine, Houston
⁹University of California, Irvine, CA
¹⁰National Institute of Health, Bethesda, MD
¹¹O'Neal Comprehensive Cancer Center at University of Alabama Birmingham, Birmingham, AL

Chonlada Laoruangroj, MD^1*, Thomas M. Habermann, MD¹, Rebecca L. King, MD², Scott Lester, MD^3*, Carrie Thompson, MD, MS⁴, Yucai Wang, MD, PhD⁴ and Thomas E. Witzig, MD¹

¹Mayo Clinic, Rochester, MN
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³Department of Radiation Oncology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic, Rochester, MN

Savreet Bains Chawla, MS^1*, Shibing Yang, PhD^1*, Jing He, PhD^1*, Monika Jun, MPH^1*, Nicole Heaps, PhD^1*, Anthony Wang, MPH, PhD^2*, Junhua Yu, PhD^3*, Chenxue Liang, MS, MPH^4*, Allison Keshishian, MPH^4* and Jon Ukropec, MD, PhD^1*

¹Genmab US, Inc., Plainsboro, NJ
²AbbVie, Inc., Chicago, IL
³AbbVie Inc., North Chicago, IL
⁴Genesis Research, Hoboken, NJ

Narendranath Epperla, MD, MS¹, Kaitlin Annunzio, DO², Geoffrey P. Shouse, PhD, DO³, Natalie S. Grover, MD⁴, Pallawi Torka, MD⁵, Marcus P Watkins, PhD^6*, Andrea Carolina Anampa-Guzmán, MD^7*, Timothy S. Oh, MD^8*, Heather Reves, MS, BS^9*, Montreh Tavakkoli, MD¹⁰, Emily Hansinger^11*, Beth Christian, MD², Colin Thomas, MD¹¹, Stefan K. Barta, MD¹², Praveen Ramakrishnan Geethakumari, MD, MS¹³, Reem Karmali, MD, MSc¹⁴, Nancy L. Bartlett, MD⁶ and Adam J Olszewski, MD¹⁵

¹The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
²The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
³City of Hope Comprehensive Cancer Center, Duarte, CA
⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁷Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁹Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
¹⁰Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
¹¹Thomas Jefferson University Hospital, Philadelphia, PA
¹²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
¹³Section of Hematological Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
¹⁴Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁵Brown University, Providence, RI

Ruby Arora, BA¹, John Lefante, PhD^2* and Nakhle S. Saba, MD³

¹Tulane University School of Medicine, Collierville, TN
²Tulane University School of Public Health, New Orleans, LA
³Tulane University HSC, New Orleans, LA

Amy M Horowitz, PharmD^1,2*, Zohra Nooruddin, MD^1,3, Michael Mader, MS^1,3*, Kathleen Franklin, RN^1*, Madison Williams, MD^4*, Ryan Williams, MD^5*, Jean-Pierre Blaize, MD^6*, Snegha Ananth, MBBS^1,3, Michael Meansup Song, MD^7*, Brian Warnecke, DO^1,3*, Abhishek Pandya, DO^1,3*, Lakene Raissa Djoufack Djoumessi, MD^1,3*, Lindsey Lu, PharmD^8*, Phillip Nazarewicz, BS^1*, Manuel Espinoza-Gutarra, MD^9*, Kana Tai Lucero, MD^1,3*, Jennifer Whitehead, MS^1*, Alaq Al-Abayechi, MD^1,3*, Lauren Boyle, DO^1,3*, Sophia Lee, MD^1,3, Gabriel Roman Souza, MD^1,3, Amna Naqvi, BS^1,3*, Esteban Toro Velez, MD³, Ian Mines, DO^1,3 and Supreet Kaur, MD^1,3

¹South Texas Veterans Health Care System, San Antonio, TX
²University of Texas College of Pharmacy, Austin, TX
³University of Texas Health-San Antonio, San Antonio, TX
⁴University of Texas MD Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston
⁶Augusta Oncology, Augusta, GA
⁷Baylor College of Medicine, Houston
⁸Palo Alto Veterans Affairs, Palo Alto, CA
⁹O'Neal Comprehensive Cancer Center at University of Alabama Birmingham, Birmingham, AL

Lekha Yadukumar, MBBS¹ and Maya Gogtay, MD²

¹Internal Medicine, Wright Center for Graduate Medical Education, Scranton, PA
²Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE

Jing-Zhou Hou^1,2, Simon Blanc³, Gregory A Maglinte, PhD, MPH^4*, Anupama Vasudevan^3*, Anna Rui^3*, Michael Gart, MBA^5*, Hoa Pham, PharmD^4*, Lindsay Aton, MHSA^3*, Brandon Wang^3* and Rushir Choksi^6*

¹Hematology and BMT, Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
²University of Pittsburgh Medical Center, Pittsburgh, PA
³Integra Connect PrecisionQ, West Palm Beach, FL
⁴BeiGene USA, Inc, San Mateo, CA
⁵Integra Connect, West Palm Beach, FL
⁶University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA

Ashley E Rosko, MD¹, Mohamed Elsaid, PhD^2*, Sarah A Wall, MD, MPH³, Alice Mims, MD⁴, Jennifer A. Woyach, MD⁵, Carolyn Presley, MD^6*, Nowshin Islam^5* and Christin E. Burd, PhD^1*

¹The Ohio State University, Columbus, OH
²The Ohio State University, Columbus
³Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁴Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵Division of Hematology, The Ohio State University, Columbus, OH
⁶Division of Medical Oncology, The Ohio State University, Columbus, OH

Smith Giri, MD, MS^1*, Clare Ubersax, BS^1*, Abigail Tucker, MSPH^1*, Susan Bal, MD¹, Kelly Godby, MD^1*, Luciano Costa, MD, PhD¹, Smita Bhatia, MD, MPH¹, Grant Williams, MD^1*, Gayathri Ravi, MD¹, Mayur Narkhede, MD^1*, Donna Murdaugh, PhD^1* and Monica Pasala^2*

¹University of Alabama at Birmingham, Birmingham, AL
²University of South Alabama, Hoover

Muhammad Farooq, MD¹, Muhammad Ammad-ud-din, MD^2*, Moazzam Shahzad, MD^1,3, Asmat Jahan, Pharm.D^4* and Michael V. Jaglal, MD⁵

¹H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
³H. Lee Moffitt Cancer Center, Tampa, FL
⁴University of Georgia College of Pharmacy, Athens
⁵Department of Hematology/Oncology, Moffitt Cancer Center, Tampa, FL

Olisaemeka Ogbue¹, Serhan Unlu, MD^1*, Danai Dima, MD¹, Carlos Bravo-Perez, MD, PhD^1,2*, Nakisha D Williams, MBBS^1*, Arooj Ahmed, MD^1*, Sindhusha Veeraballi^1*, Arda Durmaz, PhD^1*, Fauzia Ullah, MD^1*, Carmelo Gurnari, MD^1,3, Valeria Visconte, PhD¹ and Jaroslaw P. Maciejewski, M.D., Ph.D., FACP¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
³Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Shengli He^1*, Menghao Chen^2* and Yi Miao, MD^3,4*

¹Oncology Department, Minhang Branch of Fudan University Shanghai Cancer Center, Shanghai, China
²WLSA Shanghai Academy, Shanghai, China
³Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁴Pukou CLL Center, Jiangsu Province Hospital, Nanjing, China

Elyse Lopez, MD¹, Deepa Dongarwar^2*, Martha P. Mims, MD, PhD³ and Sara Taveras Alam, MD⁴

¹Department of Internal Medicine, Baylor College of Medicine, Houston, TX
²Department of Neurology, University of Texas McGovern Medical School, Houston, TX
³Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
⁴Division of Hematology Oncology, University of Texas McGovern Medical School, Houston, TX

Ronit Gurion, MD^1,2*, Dmitri Guz, MD^2,3*, Meirav Kedmi, MD^2,4*, Chava Perry, MD^2,5*, Irit Avivi Mazza, MD^2,6*, Netanel A. Horowitz, MD^7,8*, Uri Abadi, MD^2,9*, Anat Gafter-Gvili, MD^10,11,12*, Pia Raanani, MD^1,2, Neta Goldschmidt^13,14*, Boaz Nachmias, MD^14,15* and Shlomzion Aumann, MD^14,15*

¹Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
²Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Department of Medicine A, Beilinson Campus, Rabin Medical Center, Petach Tikva, Israel
⁴Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
⁵BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁶Hematology Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel
⁷The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
⁸Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
⁹Hematology Institute, Meir Medical Center, Kfar Saba, Israel
¹⁰Department of Medicine A, Beilinson Campus, Rabin Medical Center, Petah-Tikva, Israel
¹¹Faculty of medicine, Tel Aviv University, Tel Aviv, Israel
¹²Hematology Institute, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
¹³Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
¹⁴Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
¹⁵Hebrew University, Jerusalem, Israel